Canada markets closed

Agile Therapeutics, Inc. (AGRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.2900-0.1000 (-7.19%)
At close: 04:00PM EDT
1.3200 +0.03 (+2.33%)
After hours: 06:29PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 6.31M
Enterprise Value 16.65M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.64
Price/Book (mrq)3.40
Enterprise Value/Revenue 1.17
Enterprise Value/EBITDA -0.24

Trading Information

Stock Price History

Beta (5Y Monthly) 1.57
52-Week Change 3-98.06%
S&P500 52-Week Change 3-7.05%
52 Week High 368.4000
52 Week Low 31.2500
50-Day Moving Average 35.9460
200-Day Moving Average 322.0749

Share Statistics

Avg Vol (3 month) 3365.44k
Avg Vol (10 day) 3315.62k
Shares Outstanding 54.54M
Implied Shares Outstanding 6N/A
Float 83.98M
% Held by Insiders 10.26%
% Held by Institutions 124.89%
Shares Short (Apr 28, 2022) 4286.88k
Short Ratio (Apr 28, 2022) 40.41
Short % of Float (Apr 28, 2022) 47.82%
Short % of Shares Outstanding (Apr 28, 2022) 47.82%
Shares Short (prior month Mar 30, 2022) 432.09k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:40
Last Split Date 3Apr 26, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,224.43%

Management Effectiveness

Return on Assets (ttm)-99.06%
Return on Equity (ttm)-367.94%

Income Statement

Revenue (ttm)5.75M
Revenue Per Share (ttm)2.16
Quarterly Revenue Growth (yoy)1,418.10%
Gross Profit (ttm)-6.62M
EBITDA -68.09M
Net Income Avi to Common (ttm)-69.53M
Diluted EPS (ttm)-26.1610
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.74M
Total Cash Per Share (mrq)0.82
Total Debt (mrq)13.19M
Total Debt/Equity (mrq)480.90
Current Ratio (mrq)0.56
Book Value Per Share (mrq)0.55

Cash Flow Statement

Operating Cash Flow (ttm)-65.28M
Levered Free Cash Flow (ttm)-43.45M